AxoGen
Stock Forecast, Prediction & Price Target
AxoGen Financial Estimates
AxoGen Revenue Estimates
AxoGen EBITDA Estimates
AxoGen Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $127.35M N/A | $138.58M 8.81% | $159.01M 14.74% | Avg: $202.31M Low: $202.31M High: $202.31M avg. 27.23% | Avg: $226.42M Low: $226.42M High: $226.42M avg. 11.91% | Avg: $257.45M Low: $257.45M High: $257.45M avg. 13.70% | Avg: $284.9M Low: $284.9M High: $284.9M avg. 10.66% |
Net Income
% change YoY
| $-28.06M N/A | $-27.33M 2.59% | $-21.71M 20.55% | Avg: $5.68M Low: $5.68M High: $5.68M avg. 126.17% | Avg: $13.98M Low: $13.98M High: $13.98M avg. 146.09% | Avg: $17.58M Low: $17.58M High: $17.58M avg. 25.68% | Avg: $15.43M Low: $15.43M High: $15.43M avg. -12.19% |
EBITDA
% change YoY
| $-20.95M N/A | $-25.08M -19.71% | $-13.32M 46.86% | Avg: $-35.09M Low: $-35.09M High: $-35.09M avg. -163.28% | Avg: $-39.27M Low: $-39.27M High: $-39.27M avg. -11.91% | Avg: $-44.65M Low: $-44.65M High: $-44.65M avg. -13.70% | Avg: $-49.41M Low: $-49.41M High: $-49.41M avg. -10.66% |
EPS
% change YoY
| -$0.68 N/A | -$0.65 4.41% | -$0.51 21.53% | Avg: $0.13 Low: $0.13 High: $0.13 avg. 125.99% | Avg: $0.33 Low: $0.33 High: $0.33 avg. 146.09% | Avg: $0.41 Low: $0.41 High: $0.41 avg. 25.68% | Avg: $0.36 Low: $0.36 High: $0.36 avg. -12.19% |
Operating Expenses
% change YoY
| $129.84M N/A | $144.14M 11.01% | $149.33M 3.60% | Avg: $172.28M Low: $172.28M High: $172.28M avg. 15.36% | Avg: $192.81M Low: $192.81M High: $192.81M avg. 11.91% | Avg: $219.23M Low: $219.23M High: $219.23M avg. 13.70% | Avg: $242.60M Low: $242.60M High: $242.60M avg. 10.66% |
FAQ
What is AxoGen stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 71.44% in 2025-2028.
We have gathered data from N/A analysts. Their low estimate is 5.68M, average is 5.68M and high is 5.68M.
What is AxoGen stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 15.87% in 2025-2028.
We have gathered data from N/A analysts. Their low revenue estimate is $202.31M, average is $202.31M and high is $202.31M.
What is AxoGen stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 71.39% in 2025-2028.
We have gathered data from N/A analysts. Their low earnings per share estimate is $0.13, average is $0.13 and high is $0.13.